Benzinga | Aug 12, 2021 04:38PM EDT

Eledon Pharmaceuticals Q2 EPS $(0.50) Beats $(0.57) Estimate

Eledon Pharmaceuticals (NASDAQ:ELDN) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.57) by 12.28 percent. This is a 233.33 percent decrease over losses of $(0.15) per share from the same period last year.